Clinical Trials List
Protocol NumberCTD-ILD-01
Active
2022-01-01 - 2026-02-28
Phase I/II
Recruiting1
-
Trial Applicant
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Joung-Liang Lan Division of Rheumatology
- 李光申 Division of Orthopedics
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
10 participants
-
Global
0 participants
